Treatment

Tuberculosis is treatable and curable. The sputum from the lungs of a person with the symptoms of tuberculosis are collected for diagnosis. Once the TB bacteria are found to be present, the patient should be isolated especially while they are in the most infectious stage. Several drugs are used in the treatment of TB. A patient must complete the full course of treatment to ensure that all the bacteria are killed. 


The most common drugs used in the treatment of tuberculosis, which are also the first-line anti-tuberculosis drugs include:
• Isoniazid
• Rifampicin (Rifampin)
• Pyrazinamide
• Ethambutol
Structural formula of the first line anti-TB drugs
The forms of some first line anti-TB drugs present

There are also second-line anti-tuberculosis drugs, being used in special conditions like in treating Multiple-drug-resistant TB (MDR-TB) and Extensively drug-resistant TB (XDR-TB). They are classified as second-line as they may be less effective than the first-line drugs, have toxic side effects (like hepatitis, depression and hallucination) or may not be available in certain countries. The six classes of second-line anti-TB drugs are aminoglycosides, polypeptides, Fluoroquinolones, thioamides, cycloserine and Terizidone.

The treatment of TB usually takes six to nine months or longer. As stated, there are two forms of TB – inactive TB and active TB. Normally, latent TB is treated with a single type of anti-TB drug to prevent its progressing into active TB. Active TB is treated with a combinations of several anti-TB drugs. The length of treatment and the drugs that should be used exactly depend on patient’s
  • age
  • weight
  • overall health
  • form of TB infected
  • infection’s location
  • drug resistance
Patients may experience side effects like nausea, vomiting, headache, loss of appetite, upset stomach and so on after taking the anti-TB drugs. Consult the doctors immediately for some medical advice if the side effects get worsen or any other serious side effect occurs.  

Anti-TB drugs are only able to kill drug-sensitive strain of TB bacteria, leaving resistant ones behind. Drug resistance is a result of the mutation in the bacterial DNA. There are several reasons that increase the chance of mutation:
• TB is left untreated
• patient stops the treatment before all the bacteria are being killed
(Some patients stop their treatment after they feel better without knowing that if they are not completely cured, M. tuberculosis may develop resistance to the drugs used)

Multiple-drug-resistant TB (MDR-TB)
MDR-TB is the tuberculosis that is resistant to at least two main drugs used to cure TB – Isoniazid & Rifampicin (which are known as the two most effective and successful first-line anti-TB drugs)


Extensively drug-resistant TB (XDR-TB)
XDR-TB is the tuberculosis that is resistant to first-line anti-TB drugs and the drugs used to treat MDR-TB.


The resistant TB strains would not be cured by a standard six-to-nine month treatment using first-line anti-TB drugs. They required longer term treatment(can take up to two years or more) and more expensive drugs. Normally, MDR-TB needs long term treatment with second-line anti-TB drugs while XDR-TB needs extensive chemotherapy for up to two years. 


Since completing treatment is important to reduce the risk of having drug-resistant M. tuberculosis strains, the World Health Organization promotes DOTS (direct observation treatment, short course). Health workers help to make sure that the patients take their medicine regularly for about six to nine months.

No comments:

Post a Comment